RIBER : RIBER : 2012 FULL-YEAR EARNINGS

                           2012 FULL-YEAR EARNINGS

Bezons, April 4th, 2013 - 7 am  - RIBER, the global leader for molecular  beam 
epitaxy (MBE), is releasing its full-year earnings for 2012.

(€'000,000 - at December 31st)     2012  2011 Change
Systems revenues                   19.4  11.5   +68%
Services and accessories revenues  5.9  5.4    +9%
Cells and sources revenues          2.1  12.1   -83%
Revenues                           27.4  29.0    -5%
Gross margin                        9.1  12.4   -27%
% of revenues                     33.2% 42.9%
Operating income                    2.0   4.3   -55%
% of revenues                      7.2% 15.0%
Pre-tax earnings                    2.2   4.5   -52%
Net income                          1.9   4.3   -55%
% of revenues                      7.0% 14.8%
EBITDA                              1.8   2.7   -33%
% of revenues                      6.6%  9.3%


  *Operational profitability  (operating  margin  of  7.2%)  despite  a  less 
    favorable product mix than in 2011;

  *Achievement of the strategic revenue target on MBE, with strong growth  in 
    business in the research field;

  *Acceleration of growth in emerging markets where Riber has a  longstanding 
    presence (China, Russia, Turkey, etc.);

  *Growth in the services business;

  *Major R&D drive, ensuring future growth.

Business developments
MBE system sales,  up 68%  compared with 2011,  reflect the  dynamic level  of 
commercial  development  with  compound  semiconductor  industrial  firms  and 
research centers.

Returning to growth, the MBE  services and accessories business has  benefited 
from work carried out at the end of 2011 to further strengthen the  commercial 
and technical  organization. In  this  way, sales  picked  up 9%  despite  the 
slowdown in demand.

The cells and sources business came in lower following an exceptional year  in 
2011, marked  by  the delivery  of  major  equipment orders  for  OLED  screen 
production lines in Asia. This market is still buoyant for Riber.

Change in profitability
Profitability for the year  was affected by the  downturn in revenues and  the 
change in  the product  mix. This  trend was  compounded by  the  year-on-year 
change concerning the reversal of provisions for inventories (€0.6 million  in 
2012, versus €1.7  million in  2011). The gross  margin came  to €9.1  million 
(versus €12.4 million in 2011), representing 33.2% of revenues.

Consolidated net income totaled €1.9  million (7% of revenues), compared  with 
€4.3 million in 2011 (14.8% of revenues).

Cash represented €5.3  million at December  31st, 2012, down  €6.8 million  in 
relation to December 31st, 2011, factoring in the impact of the seasonality of
deliveries on working capital requirements,  in addition to the dividend  paid 
out for 2011, the  increase in investments and  the significant ramping up  of 
research and innovation efforts.

Proposed dividend of €0.04 per share
The Management Board will be submitting  a proposal at the General Meeting  on 
May 31st, 2013 for a dividend of €0.04 per share.

As recommended by the Management Board, and in order to support Riber's growth
strategy, the Supervisory Board decided to coopt the following new Supervisory
Board members on April 3rd, 2013:

  *Dominique  Pons,   director  at   GIE  III-V   Lab,  the   joint   Thales, 
    Alcatel-Lucent and  CEA-Leti  industrial  research  laboratory  for  III-V 

  *Gildas Sorin,  CEO  of Novaled,  the  German  firm and  world  leader  for 
    developing and marketing materials for OLED production.

Their coopting will be submitted for approval at the upcoming general  meeting 
on May 31st, 2013.

The order book represented  €15.5 million at the  end of February 2013  (€12.1 
million at end-2012), confirming the good level of the market for MBE research
systems on which  RIBER is particularly  well positioned, with  orders for  13 
machines to be delivered in 2013.

In 2013, RIBER is moving forward with the deployment of its profitable  growth 

  *Continuing to  further strengthen  RIBER's leadership  on the  market  for 
    molecular beam epitaxy machines;

  *Capitalizing on the installed base and growing sales of epitaxy equipment,
    spare parts and accessories, as well as the corresponding services;

  *Releasing a  range  of  equipment and  services  with  high  technological 
    value-added on  the  market  for strong-growth  application  fields  (OLED 
    lighting and screens, thin-layer solar cells, etc.);

  *Over the  longer  term,  integrating molecular  beam  epitaxy  within  the 
    silicon manufacturing chain.

The financial  statements  were approved  by  the Management  and  Supervisory 
Boards on April  3rd, 2013.  They will be  incorporated into  the 2012  annual 
report, which will be published on April 22nd on the French version of Riber's
internet site (www.riber.com).

Next date: 2013 first-quarter revenues on April 24th after close of trading

About RIBER:
Riber designs and  produces molecular beam  epitaxy (MBE) systems  as well  as 
evaporation  sources   and  cells   for  the   semiconductor  industry.   This 
high-technology equipment  is  essential  for the  manufacturing  of  compound 
semiconductor materials and new materials  that are used in numerous  consumer 
applications, from new information technologies  to OLED flat screens and  new 
generation solar cells.
Riber recorded €27.4 million in revenues  in 2012 and employs 111 people.  The 
company is ISO9001 certified.
Riber is listed on  NYSE-Euronext Paris, Compartment "C",  and is part of  the 
CAC Small, CAC Mid & Small, CAC Technology and CAC T. HARD. & EQ indices.
Riber is one of  the best-rated companies in  the Gaïa-index, the leading  SRI 
index for French mid-caps.

ISIN: FR0000075954 - RIB
Reuters: RIBE.PA
Bloomberg: RIB: FP
OSEO-approved innovative company

RIBER                  CALYPTUS
Olivier Handschumacher Cyril Combe
tel: +33 1 39 96 65 00 tel: +33 1 53 65 68 68
invest@riber.com      cyril.combe@calyptus.net




This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: RIBER via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.